A prospective randomised controlled trial of management of recurrent nosebleeds in children: antiseptic cream alone versus antiseptic cream with nasal cautery
Phase 1
- Conditions
- Recurrent Paediatric Epistaxis
- Registration Number
- EUCTR2005-006089-32-GB
- Lead Sponsor
- HS Greater Glasgow - Yorkhill Division
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- Not specified
- Target Recruitment
- 216
Inclusion Criteria
Children aged 1-14 with a history of repeated epistaxis with at lease 1 episode in the previous 4 weeks prior to attending the ENT clinic.
Are the trial subjects under 18? yes
Number of subjects for this age range:
F.1.2 Adults (18-64 years) no
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Known bleeding disorders. Allergy to peanuts, peanut oil, neomycin or chlorhexidine (these are contained in the Naseptin cream). Other causes of nose bleeding eg. tumour.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: To determine whether silver nitrate cautery has any therapeutic effect in addition to 4 weeks of Naseptin cream in the management of recurrent paediatric epistaxis in patients with visible vessels in their nasal septum.;Secondary Objective: Not applicable.;Primary end point(s): Proportion of children with no nose bleeds in a 4 week period prior to clinical review.
- Secondary Outcome Measures
Name Time Method